img

Global Human Rabies Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Rabies Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
The global Human Rabies Vaccines market size was US$ 1056 million in 2024 and is forecast to a readjusted size of US$ 1352.3 million by 2034 with a CAGR of 3.5% during the forecast period 2024-2034.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.
In terms of sales (consumption) side, this report focuses on the sales of Human Rabies Vaccines by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Human Rabies Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Human Rabies Vaccines market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Sanofi Pasteur，Inc.
Novartis Vaccines and Diagnostics Ltd.
Cadila Pharmaceuticals Ltd.
GlaxoSmithKline Biologicals
Merck＆Co Inc.
Wyeth pharmaceuticals
Berna Biotech Ltd.
Medimmune LLC
By Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
By Application
Pre-Exposure Prophylaxis
Post-Exposure Prophylaxis
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Human Rabies Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Human Rabies Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Rabies Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Human Rabies Vaccines Definition
1.2 Market by Type
1.2.1 Global Human Rabies Vaccines Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Human Rabies Vaccines Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Pre-Exposure Prophylaxis
1.3.3 Post-Exposure Prophylaxis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Human Rabies Vaccines Sales
2.1 Global Human Rabies Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Human Rabies Vaccines Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Human Rabies Vaccines Revenue by Region
2.3.1 Global Human Rabies Vaccines Revenue by Region (2018-2023)
2.3.2 Global Human Rabies Vaccines Revenue by Region (2024-2034)
2.4 Global Human Rabies Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Human Rabies Vaccines Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Human Rabies Vaccines Sales Quantity by Region
2.6.1 Global Human Rabies Vaccines Sales Quantity by Region (2018-2023)
2.6.2 Global Human Rabies Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Human Rabies Vaccines Sales Quantity by Manufacturers
3.1.1 Global Human Rabies Vaccines Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Human Rabies Vaccines Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Human Rabies Vaccines Sales in 2024
3.2 Global Human Rabies Vaccines Revenue by Manufacturers
3.2.1 Global Human Rabies Vaccines Revenue by Manufacturers (2018-2023)
3.2.2 Global Human Rabies Vaccines Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Human Rabies Vaccines Revenue in 2024
3.3 Global Human Rabies Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Human Rabies Vaccines, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Rabies Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Rabies Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Human Rabies Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Human Rabies Vaccines Sales Quantity by Type
4.1.1 Global Human Rabies Vaccines Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Human Rabies Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Human Rabies Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Human Rabies Vaccines Revenue by Type
4.2.1 Global Human Rabies Vaccines Historical Revenue by Type (2018-2023)
4.2.2 Global Human Rabies Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Human Rabies Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Human Rabies Vaccines Price by Type
4.3.1 Global Human Rabies Vaccines Price by Type (2018-2023)
4.3.2 Global Human Rabies Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Human Rabies Vaccines Sales Quantity by Application
5.1.1 Global Human Rabies Vaccines Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Human Rabies Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Human Rabies Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Human Rabies Vaccines Revenue by Application
5.2.1 Global Human Rabies Vaccines Historical Revenue by Application (2018-2023)
5.2.2 Global Human Rabies Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Human Rabies Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Human Rabies Vaccines Price by Application
5.3.1 Global Human Rabies Vaccines Price by Application (2018-2023)
5.3.2 Global Human Rabies Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Human Rabies Vaccines Sales by Company
6.1.1 North America Human Rabies Vaccines Revenue by Company (2018-2023)
6.1.2 North America Human Rabies Vaccines Sales Quantity by Company (2018-2023)
6.2 North America Human Rabies Vaccines Market Size by Type
6.2.1 North America Human Rabies Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Human Rabies Vaccines Revenue by Type (2018-2034)
6.3 North America Human Rabies Vaccines Market Size by Application
6.3.1 North America Human Rabies Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Human Rabies Vaccines Revenue by Application (2018-2034)
6.4 North America Human Rabies Vaccines Market Size by Country
6.4.1 North America Human Rabies Vaccines Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Human Rabies Vaccines Revenue by Country (2018-2034)
6.4.3 North America Human Rabies Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Human Rabies Vaccines Sales by Company
7.1.1 Europe Human Rabies Vaccines Sales Quantity by Company (2018-2023)
7.1.2 Europe Human Rabies Vaccines Revenue by Company (2018-2023)
7.2 Europe Human Rabies Vaccines Market Size by Type
7.2.1 Europe Human Rabies Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Human Rabies Vaccines Revenue by Type (2018-2034)
7.3 Europe Human Rabies Vaccines Market Size by Application
7.3.1 Europe Human Rabies Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Human Rabies Vaccines Revenue by Application (2018-2034)
7.4 Europe Human Rabies Vaccines Market Size by Country
7.4.1 Europe Human Rabies Vaccines Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Human Rabies Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Human Rabies Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Human Rabies Vaccines Sales by Company
8.1.1 China Human Rabies Vaccines Sales Quantity by Company (2018-2023)
8.1.2 China Human Rabies Vaccines Revenue by Company (2018-2023)
8.2 China Human Rabies Vaccines Market Size by Type
8.2.1 China Human Rabies Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Human Rabies Vaccines Revenue by Type (2018-2034)
8.3 China Human Rabies Vaccines Market Size by Application
8.3.1 China Human Rabies Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Human Rabies Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Human Rabies Vaccines Sales by Company
9.1.1 APAC Human Rabies Vaccines Sales Quantity by Company (2018-2023)
9.1.2 APAC Human Rabies Vaccines Revenue by Company (2018-2023)
9.2 APAC Human Rabies Vaccines Market Size by Type
9.2.1 APAC Human Rabies Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Human Rabies Vaccines Revenue by Type (2018-2034)
9.3 APAC Human Rabies Vaccines Market Size by Application
9.3.1 APAC Human Rabies Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Human Rabies Vaccines Revenue by Application (2018-2034)
9.4 APAC Human Rabies Vaccines Market Size by Region
9.4.1 APAC Human Rabies Vaccines Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Human Rabies Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Human Rabies Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Rabies Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Human Rabies Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Human Rabies Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Human Rabies Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Sanofi Pasteur，Inc.
11.1.1 Sanofi Pasteur，Inc. Company Information
11.1.2 Sanofi Pasteur，Inc. Overview
11.1.3 Sanofi Pasteur，Inc. Human Rabies Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Sanofi Pasteur，Inc. Human Rabies Vaccines Products and Services
11.1.5 Sanofi Pasteur，Inc. Human Rabies Vaccines SWOT Analysis
11.1.6 Sanofi Pasteur，Inc. Recent Developments
11.2 Novartis Vaccines and Diagnostics Ltd.
11.2.1 Novartis Vaccines and Diagnostics Ltd. Company Information
11.2.2 Novartis Vaccines and Diagnostics Ltd. Overview
11.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Products and Services
11.2.5 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines SWOT Analysis
11.2.6 Novartis Vaccines and Diagnostics Ltd. Recent Developments
11.3 Cadila Pharmaceuticals Ltd.
11.3.1 Cadila Pharmaceuticals Ltd. Company Information
11.3.2 Cadila Pharmaceuticals Ltd. Overview
11.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Products and Services
11.3.5 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines SWOT Analysis
11.3.6 Cadila Pharmaceuticals Ltd. Recent Developments
11.4 GlaxoSmithKline Biologicals
11.4.1 GlaxoSmithKline Biologicals Company Information
11.4.2 GlaxoSmithKline Biologicals Overview
11.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 GlaxoSmithKline Biologicals Human Rabies Vaccines Products and Services
11.4.5 GlaxoSmithKline Biologicals Human Rabies Vaccines SWOT Analysis
11.4.6 GlaxoSmithKline Biologicals Recent Developments
11.5 Merck＆Co Inc.
11.5.1 Merck＆Co Inc. Company Information
11.5.2 Merck＆Co Inc. Overview
11.5.3 Merck＆Co Inc. Human Rabies Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Merck＆Co Inc. Human Rabies Vaccines Products and Services
11.5.5 Merck＆Co Inc. Human Rabies Vaccines SWOT Analysis
11.5.6 Merck＆Co Inc. Recent Developments
11.6 Wyeth pharmaceuticals
11.6.1 Wyeth pharmaceuticals Company Information
11.6.2 Wyeth pharmaceuticals Overview
11.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Wyeth pharmaceuticals Human Rabies Vaccines Products and Services
11.6.5 Wyeth pharmaceuticals Human Rabies Vaccines SWOT Analysis
11.6.6 Wyeth pharmaceuticals Recent Developments
11.7 Berna Biotech Ltd.
11.7.1 Berna Biotech Ltd. Company Information
11.7.2 Berna Biotech Ltd. Overview
11.7.3 Berna Biotech Ltd. Human Rabies Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Berna Biotech Ltd. Human Rabies Vaccines Products and Services
11.7.5 Berna Biotech Ltd. Human Rabies Vaccines SWOT Analysis
11.7.6 Berna Biotech Ltd. Recent Developments
11.8 Medimmune LLC
11.8.1 Medimmune LLC Company Information
11.8.2 Medimmune LLC Overview
11.8.3 Medimmune LLC Human Rabies Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Medimmune LLC Human Rabies Vaccines Products and Services
11.8.5 Medimmune LLC Human Rabies Vaccines SWOT Analysis
11.8.6 Medimmune LLC Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Human Rabies Vaccines Value Chain Analysis
12.2 Human Rabies Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Rabies Vaccines Production Mode & Process
12.4 Human Rabies Vaccines Sales and Marketing
12.4.1 Human Rabies Vaccines Sales Channels
12.4.2 Human Rabies Vaccines Distributors
12.5 Human Rabies Vaccines Customers
13 Market Dynamics
13.1 Human Rabies Vaccines Industry Trends
13.2 Human Rabies Vaccines Market Drivers
13.3 Human Rabies Vaccines Market Challenges
13.4 Human Rabies Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Rabies Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Vero Cell Rabies Vaccine
Table 3. Major Manufacturers of BHK
Table 4. Major Manufacturers of Chick Embryo Cell Rabies Vaccine
Table 5. Major Manufacturers of Others
Table 6. Global Human Rabies Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Human Rabies Vaccines Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Human Rabies Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Human Rabies Vaccines Revenue Market Share by Region (2018-2023)
Table 10. Global Human Rabies Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Human Rabies Vaccines Revenue Market Share by Region (2024-2034)
Table 12. Global Human Rabies Vaccines Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 13. Global Human Rabies Vaccines Sales by Region (2018-2023) & (K Units)
Table 14. Global Human Rabies Vaccines Sales Market Share by Region (2018-2023)
Table 15. Global Human Rabies Vaccines Sales by Region (2024-2034) & (K Units)
Table 16. Global Human Rabies Vaccines Sales Market Share by Region (2024-2034)
Table 17. Global Human Rabies Vaccines Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 18. Global Human Rabies Vaccines Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global Human Rabies Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Human Rabies Vaccines Revenue Share by Manufacturers (2018-2023)
Table 21. Global Human Rabies Vaccines Price by Manufacturers 2018-2023 (USD/Unit)
Table 22. Global Key Players of Human Rabies Vaccines, Industry Ranking, 2021 VS 2024
Table 23. Global Human Rabies Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Human Rabies Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Rabies Vaccines as of 2024)
Table 25. Global Key Manufacturers of Human Rabies Vaccines, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Human Rabies Vaccines, Product Offered and Application
Table 27. Global Key Manufacturers of Human Rabies Vaccines, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Human Rabies Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 30. Global Human Rabies Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 31. Global Human Rabies Vaccines Sales Quantity Share by Type (2018-2023)
Table 32. Global Human Rabies Vaccines Sales Quantity Share by Type (2024-2034)
Table 33. Global Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Human Rabies Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Human Rabies Vaccines Revenue Share by Type (2018-2023)
Table 36. Global Human Rabies Vaccines Revenue Share by Type (2024-2034)
Table 37. Human Rabies Vaccines Price by Type (2018-2023) & (USD/Unit)
Table 38. Global Human Rabies Vaccines Price Forecast by Type (2024-2034) & (USD/Unit)
Table 39. Global Human Rabies Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 40. Global Human Rabies Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 41. Global Human Rabies Vaccines Sales Quantity Share by Application (2018-2023)
Table 42. Global Human Rabies Vaccines Sales Quantity Share by Application (2024-2034)
Table 43. Global Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Human Rabies Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Human Rabies Vaccines Revenue Share by Application (2018-2023)
Table 46. Global Human Rabies Vaccines Revenue Share by Application (2024-2034)
Table 47. Human Rabies Vaccines Price by Application (2018-2023) & (USD/Unit)
Table 48. Global Human Rabies Vaccines Price Forecast by Application (2024-2034) & (USD/Unit)
Table 49. North America Human Rabies Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America Human Rabies Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 51. North America Human Rabies Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 52. North America Human Rabies Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 53. North America Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America Human Rabies Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Human Rabies Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 56. North America Human Rabies Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 57. North America Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America Human Rabies Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Human Rabies Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America Human Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America Human Rabies Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Human Rabies Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 63. North America Human Rabies Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 64. Europe Human Rabies Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 65. Europe Human Rabies Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe Human Rabies Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Europe Human Rabies Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 68. Europe Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Human Rabies Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Human Rabies Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Human Rabies Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 72. Europe Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Human Rabies Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Human Rabies Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe Human Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Human Rabies Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Human Rabies Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Human Rabies Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 79. China Human Rabies Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 80. China Human Rabies Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 81. China Human Rabies Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 82. China Human Rabies Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 83. China Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Human Rabies Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Human Rabies Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 86. China Human Rabies Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 87. China Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Human Rabies Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Human Rabies Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 90. APAC Human Rabies Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC Human Rabies Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 92. APAC Human Rabies Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 93. APAC Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC Human Rabies Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Human Rabies Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 96. APAC Human Rabies Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 97. APAC Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC Human Rabies Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Human Rabies Vaccines Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC Human Rabies Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC Human Rabies Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Human Rabies Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 103. APAC Human Rabies Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 104. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 119. Sanofi Pasteur，Inc. Company Information
Table 120. Sanofi Pasteur，Inc. Description and Overview
Table 121. Sanofi Pasteur，Inc. Human Rabies Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 122. Sanofi Pasteur，Inc. Human Rabies Vaccines Product and Services
Table 123. Sanofi Pasteur，Inc. Human Rabies Vaccines SWOT Analysis
Table 124. Sanofi Pasteur，Inc. Recent Developments
Table 125. Novartis Vaccines and Diagnostics Ltd. Company Information
Table 126. Novartis Vaccines and Diagnostics Ltd. Description and Overview
Table 127. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 128. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product and Services
Table 129. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines SWOT Analysis
Table 130. Novartis Vaccines and Diagnostics Ltd. Recent Developments
Table 131. Cadila Pharmaceuticals Ltd. Company Information
Table 132. Cadila Pharmaceuticals Ltd. Description and Overview
Table 133. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 134. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product and Services
Table 135. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines SWOT Analysis
Table 136. Cadila Pharmaceuticals Ltd. Recent Developments
Table 137. GlaxoSmithKline Biologicals Company Information
Table 138. GlaxoSmithKline Biologicals Description and Overview
Table 139. GlaxoSmithKline Biologicals Human Rabies Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 140. GlaxoSmithKline Biologicals Human Rabies Vaccines Product and Services
Table 141. GlaxoSmithKline Biologicals Human Rabies Vaccines SWOT Analysis
Table 142. GlaxoSmithKline Biologicals Recent Developments
Table 143. Merck＆Co Inc. Company Information
Table 144. Merck＆Co Inc. Description and Overview
Table 145. Merck＆Co Inc. Human Rabies Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 146. Merck＆Co Inc. Human Rabies Vaccines Product and Services
Table 147. Merck＆Co Inc. Human Rabies Vaccines SWOT Analysis
Table 148. Merck＆Co Inc. Recent Developments
Table 149. Wyeth pharmaceuticals Company Information
Table 150. Wyeth pharmaceuticals Description and Overview
Table 151. Wyeth pharmaceuticals Human Rabies Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 152. Wyeth pharmaceuticals Human Rabies Vaccines Product and Services
Table 153. Wyeth pharmaceuticals Human Rabies Vaccines SWOT Analysis
Table 154. Wyeth pharmaceuticals Recent Developments
Table 155. Berna Biotech Ltd. Company Information
Table 156. Berna Biotech Ltd. Description and Overview
Table 157. Berna Biotech Ltd. Human Rabies Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 158. Berna Biotech Ltd. Human Rabies Vaccines Product and Services
Table 159. Berna Biotech Ltd. Human Rabies Vaccines SWOT Analysis
Table 160. Berna Biotech Ltd. Recent Developments
Table 161. Medimmune LLC Company Information
Table 162. Medimmune LLC Description and Overview
Table 163. Medimmune LLC Human Rabies Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 164. Medimmune LLC Human Rabies Vaccines Product and Services
Table 165. Medimmune LLC Human Rabies Vaccines SWOT Analysis
Table 166. Medimmune LLC Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Human Rabies Vaccines Distributors List
Table 170. Human Rabies Vaccines Customers List
Table 171. Human Rabies Vaccines Market Trends
Table 172. Human Rabies Vaccines Market Drivers
Table 173. Human Rabies Vaccines Market Challenges
Table 174. Human Rabies Vaccines Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rabies Vaccines Product Picture
Figure 2. Global Human Rabies Vaccines Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Human Rabies Vaccines Market Share by Type in 2024 & 2034
Figure 4. Vero Cell Rabies Vaccine Product Picture
Figure 5. BHK Product Picture
Figure 6. Chick Embryo Cell Rabies Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Rabies Vaccines Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global Human Rabies Vaccines Market Share by Application in 2024 & 2034
Figure 10. Pre-Exposure Prophylaxis
Figure 11. Post-Exposure Prophylaxis
Figure 12. Human Rabies Vaccines Report Years Considered
Figure 13. Global Human Rabies Vaccines Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Human Rabies Vaccines Revenue 2018-2034 (US$ Million)
Figure 15. Global Human Rabies Vaccines Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Human Rabies Vaccines Sales Quantity 2018-2034 (K Units)
Figure 17. Global Human Rabies Vaccines Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Human Rabies Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Human Rabies Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. North America Human Rabies Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Human Rabies Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. Europe Human Rabies Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Human Rabies Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. China Human Rabies Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Human Rabies Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. APAC Human Rabies Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Human Rabies Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Human Rabies Vaccines Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Human Rabies Vaccines Revenue in 2024
Figure 31. Human Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Human Rabies Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Human Rabies Vaccines Revenue Market Share by Type (2018-2034)
Figure 34. Global Human Rabies Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Human Rabies Vaccines Revenue Market Share by Application (2018-2034)
Figure 36. North America Human Rabies Vaccines Revenue Market Share by Company in 2024
Figure 37. North America Human Rabies Vaccines Sales Quantity Market Share by Company in 2024
Figure 38. North America Human Rabies Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Human Rabies Vaccines Revenue Market Share by Type (2018-2034)
Figure 40. North America Human Rabies Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Human Rabies Vaccines Revenue Market Share by Application (2018-2034)
Figure 42. North America Human Rabies Vaccines Revenue Share by Country (2018-2034)
Figure 43. North America Human Rabies Vaccines Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Human Rabies Vaccines Sales Quantity Market Share by Company in 2024
Figure 47. Europe Human Rabies Vaccines Revenue Market Share by Company in 2024
Figure 48. Europe Human Rabies Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Human Rabies Vaccines Revenue Market Share by Type (2018-2034)
Figure 50. Europe Human Rabies Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Human Rabies Vaccines Revenue Market Share by Application (2018-2034)
Figure 52. Europe Human Rabies Vaccines Revenue Share by Country (2018-2034)
Figure 53. Europe Human Rabies Vaccines Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 55. France Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 59. China Human Rabies Vaccines Sales Quantity Market Share by Company in 2024
Figure 60. China Human Rabies Vaccines Revenue Market Share by Company in 2024
Figure 61. China Human Rabies Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Human Rabies Vaccines Revenue Market Share by Type (2018-2034)
Figure 63. China Human Rabies Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Human Rabies Vaccines Revenue Market Share by Application (2018-2034)
Figure 65. APAC Human Rabies Vaccines Sales Quantity Market Share by Company in 2024
Figure 66. APAC Human Rabies Vaccines Revenue Market Share by Company in 2024
Figure 67. APAC Human Rabies Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Human Rabies Vaccines Revenue Market Share by Type (2018-2034)
Figure 69. APAC Human Rabies Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Human Rabies Vaccines Revenue Market Share by Application (2018-2034)
Figure 71. APAC Human Rabies Vaccines Revenue Share by Region (2018-2034)
Figure 72. APAC Human Rabies Vaccines Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. India Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Human Rabies Vaccines Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Human Rabies Vaccines Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Human Rabies Vaccines Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Human Rabies Vaccines Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Human Rabies Vaccines Revenue Share by Country (2018-2034)
Figure 86. Brazil Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Human Rabies Vaccines Revenue (2018-2034) & (US$ Million)
Figure 91. Human Rabies Vaccines Value Chain
Figure 92. Human Rabies Vaccines Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries